Skip to main content
editorial
. 2023 Jan 8;28(2):110–119. doi: 10.1111/resp.14443

TABLE 1.

Key recommendations for treatment of primary snoring

Key recommendation Level of evidence Level of certainty
Non‐surgical treatment
Weight loss Recommended in appropriate snoring patients in view of the additional health benefits D High
Alcohol Alcohol consumption reduction should be recommended in all patients D High
Medications Advice may include avoidance of long term use of benzodiazepines and opioids should be avoided in patients with primary snoring D Moderate
Complementary and alternative remedies Minimally harmful but uncertain long‐term utility and not advisable D Low
EPAP Minimally harmful with some treatment effect but costly long‐term use C Low
Positional therapy Considered a reasonable, mostly low risk trial option in supine dominant snorers C Moderate
Oral appliance therapy MAD should be considered first line treatment in patients with primary snoring following occlusal examination by an appropriate Dentist combined with Sleep Physician assessment B High
CPAP Option if patients are willing to trial and/or committed to CPAP use B High
Myofunctional therapy Low risk option but significant commitment is required to achieve a small reduction in snoring B Low
Surgical treatment
Nasal surgery Recommended in patients who also complain of nasal obstruction and have objective evidence of septal deviation ± turbinate hypertrophy on nasal endoscopy C High
Radiofrequency palatal surgery May be effective as a short‐term option but patients may require additional therapy. B Moderate
Uvulopalato‐pharyngoplasty Recommended treatment modality for soft palate surgery, offered to patients who have considered MAD or CPAP therapy B High
Palatal soft tissue implants Effective treatment in the short term, however have an unacceptably high rate of extrusion and limited sustained clinical benefit with the potential to worsen OSA C Moderate
Injection snoreplasty May be offered in patients with palatal flutter, however results are not consistently predictable and unlikely to be sustained long term C Low
Combination therapy Reasonable in clinical context when the risks of each and combination therapies have been discussed B Moderate